Abstract
In the clear and critical review of acute renal failure by Thadhani et al. (May 30 issue),1 the authors summarize the management issues and at present “do not recommend the routine use of dopamine for either prophylaxis or treatment of established acute renal failure.” Our experience, however, suggests that a randomized, controlled study is long overdue. Dopamine and furosemide are highly synergistic in maintaining the glomerular filtration rate in early nephrotoxic acute tubular necrosis in dogs.2 Neither drug is as effective by itself. Furthermore, a frequently cited clinical study3 and an editorial in the Lancet 4 inappropriately conclude that dopamine is ineffective in acute renal failure. Dopamine was given to normal, euvolemic patients as “prophylaxis” after elective abdominal surgery. Since patients with acute renal failure were not included, this study has no bearing on the treatment of acute renal failure. Also, the dose used may have caused vasoconstriction. The study had no statistical power to demonstrate a “protective effect,” because the incidence of acute renal failure is very low in this situation. Therefore, this study offers no evidence against low-dose dopamine as prophylaxis or treatment in acute tubular necrosis.

This publication has 9 references indexed in Scilit: